Abstract
The use of bisindolylmaleimide derivatives of staurosporine as selective inhibitors of protein kinase C (PKC) is in doubt following the report by Alessi [FEBS Lett. 402 (1997) 121–123] that Ro31‐8220 and GF109203X are potent in vitro inhibitors of p70 S6 kinase and mitogen‐activated protein kinase‐activated protein kinase‐1β, as well as of PKC. Here we show that the phorbol ester‐stimulated release of choline‐ and ethanolamine‐metabolites from C6 glioma cells due to phospholipid hydrolysis by phospholipase D (PLD) is not inhibited by rapamycin or PD98059, specific inhibitors respectively of p70 S6 kinase and MAPKK (MEK) and thus of MAPKAP kinase‐1β but is still completely blocked by Ro31‐8220. We conclude therefore that p70S6k and MAPKAP kinase‐1β as well as MAPK are not involved in signalling pathways downstream of PKC that regulate phorbol ester‐stimulated phospholipid turnover and that the inhibitory action of Ro31‐8220 occurs by blocking PKC which regulates at least one pathway to PLD activation. The PI‐3 kinase inhibitor, wortmannin, inhibits the phorbol ester‐stimulated release of ethanolamine‐ but not choline‐metabolites from C6 cells suggesting that different PLD isoforms regulate the turnover of PtdEth and PtdCho in C6 cells. Both PLD isoforms are activated via PKC but the PtdEth‐PLD is also regulated via a wortmannin‐sensitive pathway.
Bibliography
Morreale, A., Mallon, B., Beale, G., Watson, J., & Rumsby, M. (1997). Ro31â8220 inhibits protein kinase C to block the phorbol esterâstimulated release of cholineâ and ethanolamineâmetabolites from C6 glioma cells: p70 S6 kinase and MAPKAP kinaseâ1β do not function downstream of PKC in activating PLD. FEBS Letters, 417(1), 38â42. Portico.
References
29
Referenced
13
10.1016/0898-6568(94)90020-5
10.1016/0014-5793(89)81494-2
10.1042/bj2940335
10.1042/bj3060115
10.1042/bj3131039
10.1016/S0014-5793(96)01510-4
10.1042/bst021354s
- Mallon B.S. (1996) D.Phil. thesis University of York.
10.1042/bj2810597
10.1016/0304-3940(92)90547-K
10.1074/jbc.270.46.27489
10.1016/0009-3084(96)02547-9
10.1016/0005-2760(94)90186-4
10.1016/0952-7915(93)90090-F
10.1016/0165-6147(96)10016-X
10.1139/o96-050
10.1016/S0014-5793(97)00444-4
10.1016/S0929-7855(96)00552-4
10.1016/0005-2760(89)90075-1
10.1074/jbc.271.43.27018
10.1016/0014-5793(94)80490-7
10.1073/pnas.88.2.598
10.1074/jbc.270.25.14935
10.1016/S0021-9258(18)98557-1
10.1042/bj3131039
10.1016/0014-5793(93)81127-L
10.1152/physrev.1997.77.2.303
10.1126/science.1380182
10.1016/0092-8674(92)90643-Q
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 25, 2002, 1:53 p.m.) |
Deposited | 1 year, 11 months ago (Sept. 16, 2023, 12:15 p.m.) |
Indexed | 1 year, 3 months ago (May 31, 2024, 12:32 p.m.) |
Issued | 27 years, 10 months ago (Nov. 3, 1997) |
Published | 27 years, 10 months ago (Nov. 3, 1997) |
Published Online | 27 years, 9 months ago (Nov. 25, 1997) |
Published Print | 27 years, 10 months ago (Nov. 3, 1997) |
@article{Morreale_1997, title={Ro31‐8220 inhibits protein kinase C to block the phorbol ester‐stimulated release of choline‐ and ethanolamine‐metabolites from C6 glioma cells: p70 S6 kinase and MAPKAP kinase‐1β do not function downstream of PKC in activating PLD}, volume={417}, ISSN={1873-3468}, url={http://dx.doi.org/10.1016/s0014-5793(97)01252-0}, DOI={10.1016/s0014-5793(97)01252-0}, number={1}, journal={FEBS Letters}, publisher={Wiley}, author={Morreale, Angela and Mallon, Barbara and Beale, Gary and Watson, John and Rumsby, Martin}, year={1997}, month=nov, pages={38–42} }